Advanced BioMedical Technologies, Inc.
ABMT
$0.0003
$0.000150.00%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -753.10K | -759.60K | -780.20K | -672.00K | -726.40K |
| Total Depreciation and Amortization | 49.80K | 25.60K | 27.90K | 28.20K | 18.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.30K | 102.10K | 108.60K | 104.60K | 75.10K |
| Change in Net Operating Assets | 650.30K | 823.60K | 827.60K | 1.19M | 335.50K |
| Cash from Operations | 9.10K | 191.50K | 183.80K | 646.70K | -298.00K |
| Capital Expenditure | -52.50K | -51.90K | -48.30K | -30.60K | -14.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -52.50K | -51.90K | -48.30K | -30.60K | -14.10K |
| Total Debt Issued | 509.30K | 337.40K | 357.50K | 67.90K | 351.50K |
| Total Debt Repaid | -484.60K | -492.00K | -501.70K | -491.70K | -32.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.80K | -2.90K | -3.30K | -4.00K | -3.30K |
| Cash from Financing | 21.90K | -157.50K | -147.50K | -427.80K | 315.70K |
| Foreign Exchange rate Adjustments | 13.90K | 13.30K | 12.60K | 8.00K | 200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.50K | -4.70K | 400.00 | 196.10K | 3.60K |
